Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
Surgery
|
September 14, 2011
Calcifications in thyroid nodules identified on preoperative computed tomography: patterns and clinical significance
Che-Wei Wu, Gianlorenzo Dionigi, Ka-Wo Lee, et al.
Annals of Surgery
|
February 22, 2023
The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms
Greg D Sacks, Paul Shin, R Scott Braithwaite, et al.
Annals of Surgery
|
October 5, 2023
Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms
Greg D Sacks, Paul Shin, R Scott Braithwaite, et al.
BMC Palliative Care
|
March 7, 2022
Navigating a newly diagnosed cancer through clinician-facilitated discussions of health-related patient values: a qualitative analysis
Kathleen A Lynch, Camila Bernal, Danielle R Romano, et al.
Medchemcomm
|
March 13, 2012
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists
Erika E Englund, Susanne Neumann, Elena Eliseeva, et al.
BMC Neurology
|
June 10, 2016
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Flora M Hammond, David N Alexander, Andrew J Cutler, et al.
BMC Neurology
|
September 4, 2016
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Flora M Hammond, David N Alexander, Andrew J Cutler, et al.
JAMA
|
September 23, 2015
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial
Jeffrey L Cummings, Constantine G Lyketsos, Elaine R Peskind, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Aerobic exercise reverses aging-induced depth-dependent decline in cerebral microcirculation
Paul Shin, Qi Pian, Hidehiro Ishikawa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
Surgery
|
September 14, 2011
Calcifications in thyroid nodules identified on preoperative computed tomography: patterns and clinical significance
Che-Wei Wu, Gianlorenzo Dionigi, Ka-Wo Lee, et al.
Annals of Surgery
|
February 22, 2023
The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms
Greg D Sacks, Paul Shin, R Scott Braithwaite, et al.
Annals of Surgery
|
October 5, 2023
Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms
Greg D Sacks, Paul Shin, R Scott Braithwaite, et al.
BMC Palliative Care
|
March 7, 2022
Navigating a newly diagnosed cancer through clinician-facilitated discussions of health-related patient values: a qualitative analysis
Kathleen A Lynch, Camila Bernal, Danielle R Romano, et al.
Medchemcomm
|
March 13, 2012
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists
Erika E Englund, Susanne Neumann, Elena Eliseeva, et al.
BMC Neurology
|
June 10, 2016
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Flora M Hammond, David N Alexander, Andrew J Cutler, et al.
BMC Neurology
|
September 4, 2016
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Flora M Hammond, David N Alexander, Andrew J Cutler, et al.
JAMA
|
September 23, 2015
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial
Jeffrey L Cummings, Constantine G Lyketsos, Elaine R Peskind, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Aerobic exercise reverses aging-induced depth-dependent decline in cerebral microcirculation
Paul Shin, Qi Pian, Hidehiro Ishikawa, et al.
Page
of 4